About the Company
We do not have any company description for Aptose Biosciences Inc. at the moment.
Exchange
OTC
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Aptose Biosciences Inc.
Aptose Biosciences Inc. Announces Closing of $8 Million Public Offering
SAN DIEGO and TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company ...
APTO - Aptose Biosciences Inc News | Morningstar
Aptose Biosciences Inc. Announces Closing of $8 Million Public Offering GlobeNewswire Nov 25, 2024 9:15pm ...
Aptose Biosciences Inc. (APTO) Q4 2023 Earnings Call Transcript
Aptose Biosciences Inc. (APTO) Q4 2023 Earnings Call Transcript Mar. 26, 2024 8:38 PM ET Aptose Biosciences Inc. (APTOF) Stock, APS:CA Stock APTOF, APS:CA SA Transcripts 153.57K Follower s ...
Aptose Biosciences Inc. (NASDAQ:APTO) Q3 2023 Earnings Call Transcript
Aptose Biosciences Inc. beats earnings expectations. Reported EPS is $-1.76, expectations were $-2.16. Operator: Good afternoon. My name is Hope, and I will be your conference operator today.
APS:CA Aptose Biosciences Inc. - Seeking Alpha
A high-level overview of Aptose Biosciences Inc. (APS:CA) stock. View (APS:CA) real-time stock price, chart, news, analysis, analyst reviews and more.
Aptose Biosciences Files Proxy Statement, Announces Online ... - Nasdaq
Aptose Biosciences Inc.Greg Chow Senior Vice President, CFO858-926-2730 gchow@aptose.com LifeSci Advisors, LLCDan Ferry, Managing Director617-535-7746 Daniel@LifeSciAdvisors.com ...
Aptose Biosciences Inc. Company & People | APS | Barron's
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small ...
Aptose Biosciences Inc (APS) Quote | Morningstar
Learn more about the Aptose Biosciences Inc (APS: xtse) fund quote with Morningstar rating and analysis including NAV, star rating, asset allocation, capital gains, and dividends to help you stay ...
APS | Aptose Biosciences Inc. Stock Overview (Canada: Toronto) | Barron's
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small ...
Aptose Biosciences, Inc. Rings the Closing Bell - Nasdaq
ABOUT THIS EVENT Aptose Biosciences Inc. (Nasdaq: APTO), a clinical-stage company with two highly differentiated therapeutics targeting hematological malignancies including leukemias and lymphomas ...
APS | Aptose Biosciences Inc. Profile | MarketWatch
Aptose Biosciences Inc. Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies.
Similar Companies
Loading the latest forecasts...